Holen Sie sich die Stockscreener-App
270.68
0.52%
1.54
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LH?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$269.14
Offen:
$265.61
24-Stunden-Volumen:
461.37K
Relative Volume:
0.55
Marktkapitalisierung:
$22.43B
Einnahmen:
$13.48B
Nettoeinkommen (Verlust:
$764.50M
KGV:
29.85
EPS:
9.0688
Netto-Cashflow:
$1.26B
1W Leistung:
+0.62%
1M Leistung:
+6.07%
6M Leistung:
+7.33%
1J Leistung:
+11.59%
1-Tages-Spanne:
$265.29
$271.86
1-Wochen-Bereich:
$265.29
$275.37
52-Wochen-Spanne:
$209.38
$293.72
Labcorp Holdings Inc Stock (LH) Company Profile
Firmenname
Labcorp Holdings Inc
Sektor
Branche
Telefon
(336) 229-1127
Adresse
358 S MAIN ST, BURLINGTON, NC
Vergleichen Sie LH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LH
Labcorp Holdings Inc
|
270.55 | 22.31B | 13.48B | 764.50M | 1.26B | 9.0688 |
|
TMO
Thermo Fisher Scientific Inc
|
637.79 | 239.06B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
239.59 | 170.97B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
691.16 | 55.61B | 4.17B | 1.03B | 940.22M | 12.61 |
|
IQV
Iqvia Holdings Inc
|
238.62 | 41.11B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
A
Agilent Technologies Inc
|
138.76 | 39.62B | 6.95B | 1.30B | 1.15B | 4.5696 |
Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-10 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-04-02 | Eingeleitet | Redburn Atlantic | Buy |
| 2025-03-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-01-07 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-12-10 | Fortgesetzt | Jefferies | Buy |
| 2024-10-30 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-10-01 | Eingeleitet | Piper Sandler | Neutral |
| 2024-03-25 | Hochstufung | Argus | Hold → Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-09 | Eingeleitet | Evercore ISI | In-line |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2023-09-06 | Eingeleitet | HSBC Securities | Hold |
| 2022-12-12 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-09-19 | Herabstufung | Argus | Buy → Hold |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-01-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-01-11 | Hochstufung | Argus | Hold → Buy |
| 2021-01-11 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2021-01-08 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-07-14 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-07-13 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | Fortgesetzt | Deutsche Bank | Buy |
| 2020-05-15 | Hochstufung | Mizuho | Neutral → Buy |
| 2020-04-29 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-04-27 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-04-27 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2019-07-16 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-06-21 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2019-04-02 | Hochstufung | Jefferies | Hold → Buy |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2019-01-03 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | Herabstufung | Craig Hallum | Buy → Hold |
| 2018-10-30 | Herabstufung | Argus | Buy → Hold |
| 2018-10-25 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2018-10-19 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-06-07 | Hochstufung | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-05-01 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2018-03-23 | Eingeleitet | Argus | Buy |
Alle ansehen
Labcorp Holdings Inc Aktie (LH) Neueste Nachrichten
Expanded MRD Test Suite and Dividend Hike Might Change The Case For Investing In Labcorp (LH) - simplywall.st
QRG Capital Management Inc. Has $878,000 Stock Holdings in Labcorp Holdings Inc. $LH - MarketBeat
The Price Is Right For Labcorp Holdings Inc. (NYSE:LH) - 富途资讯
Labcorp Holdings Inc. $LH Shares Sold by Massachusetts Financial Services Co. MA - MarketBeat
Navera Investment Management Ltd. Sells 11,643 Shares of Labcorp Holdings Inc. $LH - MarketBeat
Community Health Completes Asset Sale to LabCorp - MSN
Labcorp Holdings' (NYSE:LH) Dividend Will Be $0.72 - simplywall.st
Labcorp Holdings (NYSE:LH) Has Announced A Dividend Of $0.72 - Yahoo Finance
Ideas Watch: Can Labcorp Holdings Inc disrupt its industryPrice Action & Daily Growth Stock Tips - baoquankhu1.vn
Labcorp to Settle Patient Privacy Dispute Over Online Trackers - Bloomberg Law News
Manning & Napier Advisors LLC Decreases Stock Position in Labcorp Holdings Inc. $LH - MarketBeat
Labcorp’s quarterly earnings preview: What you need to know - MSN
Labcorp to Announce Fourth Quarter Financial Results on February 17, 2026 - Sahm
Is Labcorp (LH) Quietly Reframing Its Oncology Innovation Story With Dividends And MRD Expansion? - Yahoo Finance
Labcorp Holdings Board Declares Quarterly Cash Dividend - The Globe and Mail
Labcorp Schedules Q4 2025 Earnings Release and Call - TipRanks
Labcorp Holdings Inc to Announce Q4 2025 Financial Results - TradingView — Track All Markets
A Look At Labcorp (LH) Valuation After Expanding Its MRD Cancer Testing Portfolio - Sahm
Labcorp Declares Quarterly Dividend - Sahm
Labcorp declares quarterly dividend of $0.72 per share By Investing.com - Investing.com Nigeria
Labcorp Holdings Inc. to Issue Quarterly Dividend of $0.72 (NYSE:LH) - MarketBeat
Press Release: Labcorp Declares Quarterly Dividend - 富途牛牛
Baird Adjusts Labcorp Price Target to $313 From $307, Maintains Outperform Rating - marketscreener.com
Labcorp Holdings Inc. Declares Quarterly Dividend, Payable on March 12, 2026 - marketscreener.com
Labcorp Holdings Maintains Quarterly Dividend of $0.72 a Share, Payable March 12 to Shareholders of Record as of Feb. 27 - marketscreener.com
Labcorp declares quarterly dividend of $0.72 per share - Investing.com
Labcorp Holdings Inc. (LH) Declares Cash Dividend for Shareholders - GuruFocus
Labcorp’s Expanded Plasma Detect MRD Portfolio Could Be A Game Changer For Labcorp Holdings (LH) - Sahm
Labcorp expands cancer recurrence testing for breast, lung, colon cancers By Investing.com - Investing.com Canada
Labcorp expands cancer recurrence testing for breast, lung, colon cancers - Investing.com
Labcorp Expands MRD Testing for Breast, Lung and Colon Cancer Recurrence Risk - Finviz
Labcorp Holdings Inc. $LH Shares Sold by Nordea Investment Management AB - MarketBeat
Labcorp Expands MRD Testing for Breast, Lung and Colon Cancer Recurrence Risk (2026-01-13) - Seeking Alpha
Assessing Labcorp Holdings (LH) Valuation After A Recent 10.5% Three Month Share Price Decline - Yahoo Finance
Best Testosterone Replacement Therapy (TRT) 2026: Taurus Meds Consumer Analysis Examines Online TRT Access and At-Home Testosterone Treatment Options - GlobeNewswire Inc.
SG Americas Securities LLC Acquires 17,723 Shares of Labcorp Holdings Inc. $LH - MarketBeat
Labcorp (LH) Up 8.1% Since Last Earnings Report: Can It Continue? - MSN
Will Labcorp Holdings Inc. stock outperform tech sector in 2025Market Risk Summary & Community Supported Trade Ideas - Улправда
Labcorp Holdings Inc. $LH Shares Sold by Cerity Partners LLC - MarketBeat
Labcorp (NYSE:LH) Downgraded by Wall Street Zen to "Hold" - MarketBeat
Labcorp’s Quarterly Earnings Preview: What You Need to Know - Yahoo Finance
NAMSA acquires Labcorp’s medical device testing assets - Yahoo Finance
Is Labcorp Holdings Inc. stock worth holding before Fed meetingMarket Risk Summary & Growth Focused Entry Reports - ulpravda.ru
Is Labcorp Holdings Inc. stock supported by strong cash flowsBreakout Watch & Weekly High Return Forecasts - ulpravda.ru
Labcorp Holdings Stock: Analyst Estimates & Ratings - MSN
Can Labcorp Holdings Inc. stock beat market expectations this quarterQuarterly Investment Review & AI Powered Buy and Sell Recommendations - Улправда
Is Labcorp Holdings Inc. stock a top pick in earnings seasonWeekly Gains Report & Stepwise Trade Execution Plans - Улправда
Is Labcorp Holdings Inc. (N6B) stock safe for risk averse investorsJuly 2025 Selloffs & Daily Profit Maximizing Tips - Улправда
Will Labcorp Holdings Inc. stock remain a Wall Street favoriteMarket Performance Recap & Long Hold Capital Preservation Plans - Улправда
Will Labcorp Holdings Inc. stock benefit from upcoming earnings reportsEarnings Summary Report & Weekly Sector Rotation Insights - Улправда
Labcorp falls as 2025 revenue guidance midpoint lowered - MSN
Finanzdaten der Labcorp Holdings Inc-Aktie (LH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.07%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):